Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Empagliflozin on Cardiac Output in Patients With Acute Heart Failure (EMPA Acute Heart Failure)

NCT03554200 is registered in ClinicalTrials.gov with RWTH Aachen University as lead sponsor.

NCT NCT03554200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03554200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Empagliflozin on Cardiac Output in Patients With Acute Heart Failure (EMPA Acute Heart Failure)
Lead sponsor
RWTH Aachen University
Phase
Phase 2
Overall status
Terminated
Start date
June 11, 2018
Completion date
October 29, 2020
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure, diabetes mellitus, type 2